Bright Minds Biosciences Stock Today
| DRUG Stock | USD 35.47 1.84 5.47% |
PerformanceMild
| Odds Of DistressSmall
|
Bright Minds is trading at 35.47 as of the 5th of August 2025. This is a 5.47 percent increase since the beginning of the trading day. The stock's lowest day price was 32.5. Bright Minds has 45 percent odds of going through some form of financial distress in the next two years and did not have a very good performance for investor during the last 90 trading days. The performance scores are derived for the period starting the 7th of May 2025 and ending today, the 5th of August 2025. Click here to learn more.
Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT medicines to improve the lives of patients with severe and life-altering diseases. The company was incorporated in 2019 and is headquartered in Vancouver, Canada. Bright Minds is traded on NASDAQ Exchange in the United States.. The company has 7.08 M outstanding shares of which 169.04 K shares are currently shorted by private and institutional investors with about 2.74 trading days to cover. More on Bright Minds Biosciences
Moving against Bright Stock
| 0.33 | MDWD | Mediwound Earnings Call This Week | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Bright Stock Highlights
| Thematic Ideas | (View all Themes) |
| Business Concentration | Pharmaceutical Products, Biotechnology, Healthcare, Biotech, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Bright Minds Biosciences (DRUG) is traded on NASDAQ Exchange in USA. It is located in 19 Vestry Street, New York, NY, United States, 10013 and employs 6 people. Bright Minds is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 238.21 M. Bright Minds Biosciences conducts business under Biotechnology sector and is part of Health Care industry. The entity has 7.08 M outstanding shares of which 169.04 K shares are currently shorted by private and institutional investors with about 2.74 trading days to cover.
Bright Minds Biosciences currently holds about 8.64 M in cash with (1.85 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.71.
Check Bright Minds Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Bright Minds Biosciences is $238.21 Million. The majority of Bright Minds Biosciences outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Bright Minds Biosciences to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Bright Minds. Please pay attention to any change in the institutional holdings of Bright Minds Biosciences as this could imply that something significant has changed or is about to change at the company. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Bright Ownership Details
Bright Minds Biosciences Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Bright Minds market risk premium is the additional return an investor will receive from holding Bright Minds long position in a well-diversified portfolio.
| Risk Adjusted Performance | 0.074 | |||
| Jensen Alpha | 0.3238 | |||
| Total Risk Alpha | (0.29) | |||
| Sortino Ratio | 0.0619 |
Bright Stock Against Markets
Bright Minds Corporate Management
| FCCP MD | Chief Officer | Profile | |
| Jan MSc | Interim Director | Profile | |
| Emer MBA | Consultant | Profile | |
| Gideon Shapiro | VP Discovery | Profile | |
| Ian McDonald | CEO, CoFounder | Profile |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Bright Minds Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bright Minds. If investors know Bright will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bright Minds listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Bright Minds Biosciences is measured differently than its book value, which is the value of Bright that is recorded on the company's balance sheet. Investors also form their own opinion of Bright Minds' value that differs from its market value or its book value, called intrinsic value, which is Bright Minds' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bright Minds' market value can be influenced by many factors that don't directly affect Bright Minds' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bright Minds' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bright Minds is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bright Minds' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.